Mucosolvan Hustensaft (Ambroxol Hydrochloride)

Ambroxol Hydrochloride works by stimulating the serous cells of the bronchial glands to increase watery secretions, enhancing ciliary activity and breaking down the structure of mucus. This reduces mucus viscosity and promotes more efficient mucociliary clearance, helping patients expectorate secretions more effectively and alleviating cough.

The specific dose of Mucosolvan Hustensaft is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of symptoms and clinical judgment. The prescriber will provide individualized dosing instructions that should be followed precisely; patients should not alter the dose without medical advice.

Safety data for Ambroxol Hydrochloride during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Mucosolvan Hustensaft. The prescriber will decide whether the therapeutic advantage outweighs any possible risk to the fetus or infant.

To order Mucosolvan Hustensaft, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After the request, the sales team will verify trade or institutional credentials, then respond with pricing, availability, shipping details and any necessary import documentation.

Both Ambroxol (Mucosolvan) and acetylcysteine act as mucolytics, but they have different mechanisms. Ambroxol primarily stimulates serous secretion and ciliary activity, while acetylcysteine directly breaks disulfide bonds in mucus proteins. Clinical choice often depends on patient tolerance, specific respiratory condition, and physician preference; both are effective for thinning mucus and improving expectoration.

Mucosolvan Hustensaft should be stored at ambient temperature, preferably below 25 °C. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and store it in its original packaging. Do not freeze the syrup. If the product appears discoloured or has an unusual odor, discard it and consult a pharmacist.

Mucosolvan Hustensaft is taken orally. The prescribed dose is measured with a calibrated dosing spoon or syringe provided with the product. It can be taken with or without food, according to the prescriber’s instructions. Patients should swallow the syrup completely and avoid chewing or diluting it unless advised by a healthcare professional.

Serious adverse reactions, although rare, include allergic responses such as hives, swelling of the face or throat, and difficulty breathing, which may indicate anaphylaxis. Severe skin reactions like Stevens‑Johnson syndrome or toxic epidermal necrolysis have also been reported. Any signs of these conditions require immediate medical attention and discontinuation of the product.

Mucosolvan Hustensaft should be avoided in individuals with a known hypersensitivity to Ambroxol Hydrochloride or any other component of the formulation. Caution is advised for patients with severe asthma or a history of bronchospasm, as the syrup may trigger airway constriction. Children under two years of age should only use the product under strict medical supervision.